Medical Device Clinical Evaluation
All Medical Devices that are placed on the market in the EU and the UK must undergo Clinical Evaluation. Clinical
Welcome to Patient Guard, your go to partner for comprehensive medical device and in vitro diagnostic (IVD) regulatory and quality assurance consultancy services. With a proven track record of excellence and a commitment to regulatory compliance, we specialize in providing tailored solutions to meet the diverse needs of our clients in the healthcare industry. Our Clinical Evaluation Services are designed to support manufacturers in navigating the complex regulatory landscape, ensuring that their medical devices and IVDs meet the highest standards of safety, efficacy, and performance.
Clinical evaluation is a cornerstone of the regulatory process for medical devices and IVDs, playing a pivotal role in demonstrating product safety and effectiveness. At Patient Guards, we understand the critical importance of conducting thorough and robust clinical evaluations in accordance with the stringent requirements outlined in EU Medical Device Regulations (MDR) 2017/745 and UK Medical Device Regulations 2002. Our team of regulatory experts possesses the knowledge, expertise, and experience necessary to guide manufacturers through every stage of the clinical evaluation process, from developing comprehensive Clinical Evaluation Plans (CEPs) to preparing detailed Clinical Evaluation Reports (CERs).
Medical device clinical evaluation is a fundamental process in the regulatory pathway for ensuring the safety, efficacy, and performance of medical devices. It involves the systematic assessment of clinical data to demonstrate that the device meets its intended purpose and benefits patients without posing unacceptable risks. This comprehensive evaluation is crucial for obtaining regulatory approval and market access for medical devices.
The clinical evaluation process begins with the identification of the device’s intended use and intended patient population. This step is essential for defining the scope of the evaluation and determining the clinical data requirements. Manufacturers must clearly define the device’s intended use, indications for use, and target patient population to guide the selection of appropriate clinical data sources and methodologies.
Once the intended use and patient population are established, manufacturers conduct a thorough review of existing clinical data relevant to the device. This includes published literature, clinical studies, post-market surveillance data, and any other available sources of clinical evidence. The goal is to gather comprehensive and robust clinical data to support the safety, efficacy, and performance of the device.
The clinical evaluation process involves several key steps, including:
Manufacturers collect and compile clinical data from various sources, including clinical investigations, literature reviews, post-market surveillance, and registries. The data collected should be relevant, reliable, and representative of the device’s intended use and patient population.
Once the clinical data is collected, it is systematically analyzed to assess the device’s safety, efficacy, and performance. This involves evaluating the clinical outcomes, adverse events, and other relevant parameters to determine the overall benefit-risk profile of the device.
Manufacturers conduct a thorough risk assessment to identify and evaluate any potential risks associated with the device. This includes assessing the probability and severity of adverse events and evaluating the mitigating measures in place to minimize risks.
The findings of the clinical evaluation are documented in a Clinical Evaluation Report (CER). The CER provides a comprehensive summary of the clinical data, analysis, and conclusions, demonstrating the device’s conformity with regulatory requirements.
The clinical evaluation process is not a one-time event but rather an ongoing process. Manufacturers are required to continuously monitor and update the clinical evaluation as new data becomes available or changes occur in the device’s intended use or patient population.
Effective clinical evaluation requires expertise in clinical research methodology, regulatory requirements, and medical device technology. Manufacturers often rely on interdisciplinary teams of clinicians, scientists, regulatory affairs professionals, and statisticians to conduct a thorough and objective evaluation of the device.
Regulatory bodies, such as the European Medicines Agency (EMA) and the Food and Drug Administration (FDA), have established guidelines and requirements for conducting clinical evaluations of medical devices. These guidelines outline the principles and best practices for collecting, analyzing, and reporting clinical data to support regulatory submissions.
In the European Union (EU), the Medical Device Regulation (MDR) 2017/745 mandates that medical device manufacturers perform clinical evaluations to demonstrate compliance with safety and performance requirements. The MDR emphasizes the importance of using clinical data to assess the safety and performance of medical devices throughout their lifecycle.
Similarly, in the United States, the FDA regulates medical devices under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA requires manufacturers to provide clinical data to support the safety and effectiveness of medical devices, especially for high-risk devices.
Medical device clinical evaluation is a critical process in the regulatory pathway for ensuring the safety, efficacy, and performance of medical devices. It involves the systematic collection, analysis, and evaluation of clinical data to demonstrate the device’s conformity with regulatory requirements. By conducting thorough and objective clinical evaluations, manufacturers can obtain regulatory approval and market access for their medical devices, ultimately benefiting patients and improving healthcare outcomes.
A well-defined and meticulously crafted Clinical Evaluation Plan (CEP) serves as the foundation for conducting a successful clinical evaluation. Our team works closely with manufacturers to develop customized CEPs that align with their specific device and intended use. We take into account factors such as device classification, intended population, and available clinical data sources to create a comprehensive plan that meets the requirements of EU MDR 2017/745 and UK Medical Device Regulations 2002.
The Clinical Evaluation Report (CER) is a comprehensive document that summarizes the results of the clinical evaluation and demonstrates the conformity of the medical device or IVD with regulatory requirements. Our regulatory experts are adept at preparing detailed CERs that meet the rigorous standards set forth by EU MDR 2017/745 and UK Medical Device Regulations 2002. We conduct thorough reviews of clinical data, analyze relevant literature, and provide evidence-based conclusions to support the safety and efficacy of the device.
Patient Guards is your trusted partner for medical device and IVD regulatory and quality assurance consultancy services. Contact us today to learn more about our Clinical Evaluation Services and how we can support your regulatory needs. Let us help you navigate the complex regulatory landscape and achieve success in the healthcare market.
Tracey Slater, Cormed
All Medical Devices that are placed on the market in the EU and the UK must undergo Clinical Evaluation. Clinical
When developing a new and exciting product it can be hard to know if it might fall under specific regulations.
Post-market surveillance (PMS) is a pivotal aspect that governs the continued monitoring and assessment of medical devices after they have
Medical Device Consultancy provides tailored expertise to your business, helping to navigate the medical device industry.
With advancements in technology,
Patient Guard Limited:
Lancaster House,
Amy Johnson Way,
Blackpool, Lancashire FY4 2RP
Patient Guard Europe UG:
Hauffstr. 41, 73765 Neuhausen,
Deutschland / Germany